Pulsipher, M A
Wayne, A S
Schultz, K R
Article History
Received: 9 December 2013
Revised: 6 February 2014
Accepted: 13 February 2014
First Online: 16 June 2014
Competing interests
: ASW is a co-inventor on patents assigned to the United States Government, as represented by the Secretary, Department of Health and Human Services (National Institutes of Health), for some of the investigational products reviewed in this paper. ASW also receives financial support through a Research Service Agreement between Children’s Hospital Los Angeles and MedImmune, LLC. KRS is Vice-Chair of a protocol run through the Therapeutic Advances in Acute Leukemia Consortium that is sponsored by SBI Biotech. The remaining authors declare no conflict of interest.